She arrived at Rutgers in 2009, specializing in plasmonic nanoparticles with an emphasis on gold, silver, and aluminum. Fabris is part of a multidisciplinary team of virologists, evolutionary biologists, mathematicians, and materials scientists joining forces across the country to design therapeutic interfering particles (TIPS) as part of the $5.2 million INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program. Fabris and her team will soon receive a grant from the Defense Advanced Research Projects Agency (DARPA) to monitor mutations in the influenza virus using gold nanoparticles with unprecedented sensitivity. She has written over 30 articles and received dozens of invitations to share her research around the world.